Effects of Ginkgo biloba leaf extract, shenmai and matrine on a human embryonic lung fibroblast fibrosis model

The aim of the present study was to investigate the effects of leaf extract (GBLE), shenmai (S), and matrine (M) on human embryonic lung fibroblasts (HELFs). HELFs were allocated into the following groups: Group A (control group), group B [transforming growth factor β1 (TGF-β1) model group], groups...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Experimental and therapeutic medicine 2018-11, Vol.16 (5), p.4289-4295
Hauptverfasser: Zhang, Xingcai, Cai, Yuli
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4295
container_issue 5
container_start_page 4289
container_title Experimental and therapeutic medicine
container_volume 16
creator Zhang, Xingcai
Cai, Yuli
description The aim of the present study was to investigate the effects of leaf extract (GBLE), shenmai (S), and matrine (M) on human embryonic lung fibroblasts (HELFs). HELFs were allocated into the following groups: Group A (control group), group B [transforming growth factor β1 (TGF-β1) model group], groups C1-3 (TGF-β1 + low-, moderate- and high-dose GBLE), groups D1-3 (TGF-β1 + low-, moderate- and high-dose S) and groups E1-3 (TGF-β1 + low-, moderate- and high-dose oM). Cell proliferation was assessed with an MTT assay and apoptosis was measured by annexin V/propidium iodide double staining and flow cytometry analysis. Collagen type I (COL-I), collagen type III (COL-III), α-smooth muscle actin (α-SMA) and extracellular superoxide dismutase (ECSOD) mRNA expression levels were measured using semi-quantitative reverse transcription-polymerase chain reaction, and protein content was measured using ELISA. The cell growth inhibition rates of the S groups were significantly higher than those of the other treatment groups (P
doi_str_mv 10.3892/etm.2018.6698
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6176143</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2125164454</sourcerecordid><originalsourceid>FETCH-LOGICAL-c481t-48ed327b3fdff0e9bd36d17867455d7f3146bb1118ddcaad4aa642e4bc543fc83</originalsourceid><addsrcrecordid>eNpdkUtrVDEYhoMotoxdupWAGxeeMbeTk7MRpNQqFNzoOuQ6k5pLTc4p9t-bccaiZpMP8vDyvXkAeInRloqZvHNL2hKExZbzWTwB53iayYARHp-eZjQLfAYuWrtF_YwcCzE-B2cUUcYmRM5BvvLemaXB4uF1yN93BeoQi1YwOuWh-7lUZZa3sO1dTipAlS1MaqkhO1gyVHC_JpWhS7o-lBwMjGveQR90LTqqthzHFhpMxbr4AjzzKjZ3cbo34NvHq6-Xn4abL9efLz_cDIYJvAxMOEvJpKm33iM3a0u5xZPgExtHO3mKGdcaYyysNUpZphRnxDFtRka9EXQD3h9z71adnDUu9x5R3tWQVH2QRQX570sOe7kr95LjiWNGe8CbU0AtP1bXFplCMy5GlV1ZmySYjGQeBZs7-vo_9LasNfd6vynMGetbbcBwpEz_jladf1wGI3mQKbtMeZApDzI7_-rvBo_0H3X0F4JunHc</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2125164454</pqid></control><display><type>article</type><title>Effects of Ginkgo biloba leaf extract, shenmai and matrine on a human embryonic lung fibroblast fibrosis model</title><source>PubMed Central</source><creator>Zhang, Xingcai ; Cai, Yuli</creator><creatorcontrib>Zhang, Xingcai ; Cai, Yuli</creatorcontrib><description>The aim of the present study was to investigate the effects of leaf extract (GBLE), shenmai (S), and matrine (M) on human embryonic lung fibroblasts (HELFs). HELFs were allocated into the following groups: Group A (control group), group B [transforming growth factor β1 (TGF-β1) model group], groups C1-3 (TGF-β1 + low-, moderate- and high-dose GBLE), groups D1-3 (TGF-β1 + low-, moderate- and high-dose S) and groups E1-3 (TGF-β1 + low-, moderate- and high-dose oM). Cell proliferation was assessed with an MTT assay and apoptosis was measured by annexin V/propidium iodide double staining and flow cytometry analysis. Collagen type I (COL-I), collagen type III (COL-III), α-smooth muscle actin (α-SMA) and extracellular superoxide dismutase (ECSOD) mRNA expression levels were measured using semi-quantitative reverse transcription-polymerase chain reaction, and protein content was measured using ELISA. The cell growth inhibition rates of the S groups were significantly higher than those of the other treatment groups (P&lt;0.05). The rate of apoptosis was significantly increased in the treatment groups compared with the model group (P&lt;0.05), and S induced a significant increase in HELF apoptosis compared with the other treatment groups (P&lt;0.05). The mRNA and protein expressions of COL-III, COL-I and α-SMA in the GBLE, S and M groups were significantly decreased, while the expression of ECSOD was significantly increased when compared with the model group (P&lt;0.05). In conclusion, GBLE, S and M inhibited the pro-fibrotic role of TGF-β1 by targeting different steps in TGF-β1-mediated fibrosis.</description><identifier>ISSN: 1792-0981</identifier><identifier>EISSN: 1792-1015</identifier><identifier>DOI: 10.3892/etm.2018.6698</identifier><identifier>PMID: 30344702</identifier><language>eng</language><publisher>Greece: Spandidos Publications UK Ltd</publisher><subject>Apoptosis ; Cell growth ; Collagen ; Drug dosages ; Extracellular matrix ; Fibroblasts ; Growth factors ; Hypotheses ; Inflammation ; Pathogenesis ; Pulmonary fibrosis ; Standard deviation ; Substance abuse treatment ; Ventilation</subject><ispartof>Experimental and therapeutic medicine, 2018-11, Vol.16 (5), p.4289-4295</ispartof><rights>Copyright Spandidos Publications UK Ltd. 2018</rights><rights>Copyright © 2018, Spandidos Publications 2018</rights><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c481t-48ed327b3fdff0e9bd36d17867455d7f3146bb1118ddcaad4aa642e4bc543fc83</citedby><cites>FETCH-LOGICAL-c481t-48ed327b3fdff0e9bd36d17867455d7f3146bb1118ddcaad4aa642e4bc543fc83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176143/pdf/$$EPDF$$P50$$Gpubmedcentral$$H</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6176143/$$EHTML$$P50$$Gpubmedcentral$$H</linktohtml><link.rule.ids>230,314,723,776,780,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30344702$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Xingcai</creatorcontrib><creatorcontrib>Cai, Yuli</creatorcontrib><title>Effects of Ginkgo biloba leaf extract, shenmai and matrine on a human embryonic lung fibroblast fibrosis model</title><title>Experimental and therapeutic medicine</title><addtitle>Exp Ther Med</addtitle><description>The aim of the present study was to investigate the effects of leaf extract (GBLE), shenmai (S), and matrine (M) on human embryonic lung fibroblasts (HELFs). HELFs were allocated into the following groups: Group A (control group), group B [transforming growth factor β1 (TGF-β1) model group], groups C1-3 (TGF-β1 + low-, moderate- and high-dose GBLE), groups D1-3 (TGF-β1 + low-, moderate- and high-dose S) and groups E1-3 (TGF-β1 + low-, moderate- and high-dose oM). Cell proliferation was assessed with an MTT assay and apoptosis was measured by annexin V/propidium iodide double staining and flow cytometry analysis. Collagen type I (COL-I), collagen type III (COL-III), α-smooth muscle actin (α-SMA) and extracellular superoxide dismutase (ECSOD) mRNA expression levels were measured using semi-quantitative reverse transcription-polymerase chain reaction, and protein content was measured using ELISA. The cell growth inhibition rates of the S groups were significantly higher than those of the other treatment groups (P&lt;0.05). The rate of apoptosis was significantly increased in the treatment groups compared with the model group (P&lt;0.05), and S induced a significant increase in HELF apoptosis compared with the other treatment groups (P&lt;0.05). The mRNA and protein expressions of COL-III, COL-I and α-SMA in the GBLE, S and M groups were significantly decreased, while the expression of ECSOD was significantly increased when compared with the model group (P&lt;0.05). In conclusion, GBLE, S and M inhibited the pro-fibrotic role of TGF-β1 by targeting different steps in TGF-β1-mediated fibrosis.</description><subject>Apoptosis</subject><subject>Cell growth</subject><subject>Collagen</subject><subject>Drug dosages</subject><subject>Extracellular matrix</subject><subject>Fibroblasts</subject><subject>Growth factors</subject><subject>Hypotheses</subject><subject>Inflammation</subject><subject>Pathogenesis</subject><subject>Pulmonary fibrosis</subject><subject>Standard deviation</subject><subject>Substance abuse treatment</subject><subject>Ventilation</subject><issn>1792-0981</issn><issn>1792-1015</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2018</creationdate><recordtype>article</recordtype><sourceid>BENPR</sourceid><recordid>eNpdkUtrVDEYhoMotoxdupWAGxeeMbeTk7MRpNQqFNzoOuQ6k5pLTc4p9t-bccaiZpMP8vDyvXkAeInRloqZvHNL2hKExZbzWTwB53iayYARHp-eZjQLfAYuWrtF_YwcCzE-B2cUUcYmRM5BvvLemaXB4uF1yN93BeoQi1YwOuWh-7lUZZa3sO1dTipAlS1MaqkhO1gyVHC_JpWhS7o-lBwMjGveQR90LTqqthzHFhpMxbr4AjzzKjZ3cbo34NvHq6-Xn4abL9efLz_cDIYJvAxMOEvJpKm33iM3a0u5xZPgExtHO3mKGdcaYyysNUpZphRnxDFtRka9EXQD3h9z71adnDUu9x5R3tWQVH2QRQX570sOe7kr95LjiWNGe8CbU0AtP1bXFplCMy5GlV1ZmySYjGQeBZs7-vo_9LasNfd6vynMGetbbcBwpEz_jladf1wGI3mQKbtMeZApDzI7_-rvBo_0H3X0F4JunHc</recordid><startdate>20181101</startdate><enddate>20181101</enddate><creator>Zhang, Xingcai</creator><creator>Cai, Yuli</creator><general>Spandidos Publications UK Ltd</general><general>D.A. Spandidos</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20181101</creationdate><title>Effects of Ginkgo biloba leaf extract, shenmai and matrine on a human embryonic lung fibroblast fibrosis model</title><author>Zhang, Xingcai ; Cai, Yuli</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c481t-48ed327b3fdff0e9bd36d17867455d7f3146bb1118ddcaad4aa642e4bc543fc83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2018</creationdate><topic>Apoptosis</topic><topic>Cell growth</topic><topic>Collagen</topic><topic>Drug dosages</topic><topic>Extracellular matrix</topic><topic>Fibroblasts</topic><topic>Growth factors</topic><topic>Hypotheses</topic><topic>Inflammation</topic><topic>Pathogenesis</topic><topic>Pulmonary fibrosis</topic><topic>Standard deviation</topic><topic>Substance abuse treatment</topic><topic>Ventilation</topic><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Xingcai</creatorcontrib><creatorcontrib>Cai, Yuli</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Experimental and therapeutic medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Xingcai</au><au>Cai, Yuli</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Effects of Ginkgo biloba leaf extract, shenmai and matrine on a human embryonic lung fibroblast fibrosis model</atitle><jtitle>Experimental and therapeutic medicine</jtitle><addtitle>Exp Ther Med</addtitle><date>2018-11-01</date><risdate>2018</risdate><volume>16</volume><issue>5</issue><spage>4289</spage><epage>4295</epage><pages>4289-4295</pages><issn>1792-0981</issn><eissn>1792-1015</eissn><abstract>The aim of the present study was to investigate the effects of leaf extract (GBLE), shenmai (S), and matrine (M) on human embryonic lung fibroblasts (HELFs). HELFs were allocated into the following groups: Group A (control group), group B [transforming growth factor β1 (TGF-β1) model group], groups C1-3 (TGF-β1 + low-, moderate- and high-dose GBLE), groups D1-3 (TGF-β1 + low-, moderate- and high-dose S) and groups E1-3 (TGF-β1 + low-, moderate- and high-dose oM). Cell proliferation was assessed with an MTT assay and apoptosis was measured by annexin V/propidium iodide double staining and flow cytometry analysis. Collagen type I (COL-I), collagen type III (COL-III), α-smooth muscle actin (α-SMA) and extracellular superoxide dismutase (ECSOD) mRNA expression levels were measured using semi-quantitative reverse transcription-polymerase chain reaction, and protein content was measured using ELISA. The cell growth inhibition rates of the S groups were significantly higher than those of the other treatment groups (P&lt;0.05). The rate of apoptosis was significantly increased in the treatment groups compared with the model group (P&lt;0.05), and S induced a significant increase in HELF apoptosis compared with the other treatment groups (P&lt;0.05). The mRNA and protein expressions of COL-III, COL-I and α-SMA in the GBLE, S and M groups were significantly decreased, while the expression of ECSOD was significantly increased when compared with the model group (P&lt;0.05). In conclusion, GBLE, S and M inhibited the pro-fibrotic role of TGF-β1 by targeting different steps in TGF-β1-mediated fibrosis.</abstract><cop>Greece</cop><pub>Spandidos Publications UK Ltd</pub><pmid>30344702</pmid><doi>10.3892/etm.2018.6698</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1792-0981
ispartof Experimental and therapeutic medicine, 2018-11, Vol.16 (5), p.4289-4295
issn 1792-0981
1792-1015
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6176143
source PubMed Central
subjects Apoptosis
Cell growth
Collagen
Drug dosages
Extracellular matrix
Fibroblasts
Growth factors
Hypotheses
Inflammation
Pathogenesis
Pulmonary fibrosis
Standard deviation
Substance abuse treatment
Ventilation
title Effects of Ginkgo biloba leaf extract, shenmai and matrine on a human embryonic lung fibroblast fibrosis model
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T06%3A19%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Effects%20of%20Ginkgo%20biloba%20leaf%20extract,%20shenmai%20and%20matrine%20on%20a%20human%20embryonic%20lung%20fibroblast%20fibrosis%20model&rft.jtitle=Experimental%20and%20therapeutic%20medicine&rft.au=Zhang,%20Xingcai&rft.date=2018-11-01&rft.volume=16&rft.issue=5&rft.spage=4289&rft.epage=4295&rft.pages=4289-4295&rft.issn=1792-0981&rft.eissn=1792-1015&rft_id=info:doi/10.3892/etm.2018.6698&rft_dat=%3Cproquest_pubme%3E2125164454%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2125164454&rft_id=info:pmid/30344702&rfr_iscdi=true